Latest Issue

    Volume 26 , Issue 2 , 2025

      Review

    • Roles of lncRNA in the crosstalk between osteogenesis and angiogenesis in the bone microenvironment

      Shihua ZHANG, Jianmin GUO, Yuting HE, Zhi’ang SU, Yao FENG, Lan ZHANG, Jun ZOU, Xiquan WENG, Yu YUAN
      Vol. 26, Issue 2, Pages: 107-123(2025) DOI: 10.1631/jzus.B2300607
      Abstract:Bone is a highly calcified and vascularized tissue. The vascular system plays a vital role in supporting bone growth and repair, such as the provision of nutrients, growth factors, and metabolic waste transfer. Moreover, the additional functions of the bone vasculature, such as the secretion of various factors and the regulation of bone-related signaling pathways, are essential for maintaining bone health. In the bone microenvironment, bone tissue cells play a critical role in regulating angiogenesis, including osteoblasts, bone marrow mesenchymal stem cells (BMSCs), and osteoclasts. Osteogenesis and bone angiogenesis are closely linked. The decrease in osteogenesis and bone angiogenesis caused by aging leads to osteoporosis. Long noncoding RNAs (lncRNAs) are involved in various physiological processes, including osteogenesis and angiogenesis. Recent studies have shown that lncRNAs could mediate the crosstalk between angiogenesis and osteogenesis. However, the mechanism by which lncRNAs regulate angiogenesis‒osteogenesis crosstalk remains unclear. In this review, we describe in detail the ways in which lncRNAs regulate the crosstalk between osteogenesis and angiogenesis to promote bone health, aiming to provide new directions for the study of the mechanism by which lncRNAs regulate bone metabolism.  
      Keywords:Long noncoding RNA (lncRNA);Osteogenesis;Bone angiogenesis;Osteoporosis;Bone microenvironment   
      2
      |
      0
      |
      0
      <HTML>
      <L-PDF>
      <Citation> <Bulk Citation> 84248995 false
      Updated:2025-02-25
    • Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer

      Jiajie FANG, Ahmad ALHASKAWI, Yanzhao DONG, Cheng CHENG, Zhijie XU, Junjie TIAN, Sahar Ahmed ABDALBARY, Hui LU
      Vol. 26, Issue 2, Pages: 124-144(2025) DOI: 10.1631/jzus.B2300614
      Abstract:Prostate cancer is the second most common cancer in men, accounting for 14.1% of new cancer cases in 2020. The aggressiveness of prostate cancer is highly variable, depending on its grade and stage at the time of diagnosis. Despite recent advances in prostate cancer treatment, some patients still experience recurrence or even progression after undergoing radical treatment. Accurate initial staging and monitoring for recurrence determine patient management, which in turn affect patient prognosis and survival. Classical imaging has limitations in the diagnosis and treatment of prostate cancer, but the use of novel molecular probes has improved the detection rate, specificity, and accuracy of prostate cancer detection. Molecular probe-based imaging modalities allow the visualization and quantitative measurement of biological processes at the molecular and cellular levels in living systems. An increased understanding of tumor biology of prostate cancer and the discovery of new tumor biomarkers have allowed the exploration of additional molecular probe targets. The development of novel ligands and advances in nano-based delivery technologies have accelerated the research and development of molecular probes. Here, we summarize the use of molecular probes in positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), optical imaging, and ultrasound imaging, and provide a brief overview of important target molecules in prostate cancer.  
      Keywords:Molecular imaging;Prostate cancer;Nuclear medicine;Prostate-specific membrane antigen (PSMA);Nanoparticle   
      6
      |
      5
      |
      0
      <HTML>
      <L-PDF>
      <Citation> <Bulk Citation> 80885171 false
      Updated:2025-02-25

      Research Article

    • Yifan LU, Siqi BAO, Hongke LUO, Qianming CHEN, Misi SI
      Vol. 26, Issue 2, Pages: 145-157(2025) DOI: 10.1631/jzus.B2300730
      Abstract:This systematic review and meta-analysis considered the results of randomized controlled clinical trials (RCTs) to evaluate the efficacy of systemic or local antibiotic therapy in peri-implantitis. Two independent authors screened publications from three electronic databases to include RCTs meeting all the inclusion and exclusion criteria. A meta-analysis was performed to evaluate the weighted mean differences in survival rate (SR) and changes in pocket probing depth (PPD), bone level (BL), and clinical attachment level (CAL). The study cohorts were defined as antibiotic and control groups with subgroups for analysis. Seven studies including 309 patients (390 implants) were considered. Within the limitations of this review, patients in the antibiotic groups exhibited significant improvements in PPD. Subgroup analysis indicated that the administration of systemic antibiotics or the use of antibiotics in non-surgical treatments did not result in a significant alteration in BL. It was established that the addition of antibiotics can ameliorate PPD and SR in the treatment of peri-implantitis, whether through surgical or non-surgical approaches, and also shows moderate performance regarding BL and CAL. Considering the lack of application of new technologies in the control group and the hardship of assessing the potential risks of antibiotics, careful clinical judgment is still necessary.  
      Keywords:Peri-implantitis;Dental implant;Oral medicine;Microbiology;Disease management;Meta-analysis   
      17
      |
      24
      |
      0
      <HTML>
      <L-PDF>
      <Citation> <Bulk Citation> 77959408 false
      Updated:2025-02-25
    • Mingtao LIU, Li LIU, Jiaxi CHEN, Zhifeng HUANG, Huiqing ZHU, Shengxuan LIN, Weitian QI, Zhangkai J. CHENG, Ning LI, Baoqing SUN
      Vol. 26, Issue 2, Pages: 158-171(2025) DOI: 10.1631/jzus.B2300433
      Abstract:The accurate and timely detection of biochemical coagulation indicators is pivotal in pulmonary and critical care medicine. Despite their reliability, traditional laboratories often lag in terms of rapid diagnosis. Point-of-care testing (POCT) has emerged as a promising alternative, which is awaiting rigorous validation. We assessed 226 samples from patients at the First Affiliated Hospital of Guangzhou Medical University using a Beckman Coulter AU5821 and a PUSHKANG POCT Biochemistry Analyzer MS100. Furthermore, 350 samples were evaluated with a Stago coagulation analyzer STAR MAX and a PUSHKANG POCT Coagulation Analyzer MC100. Metrics included thirteen biochemical indexes, such as albumin, and five coagulation indices, such as prothrombin time. Comparisons were drawn against the PUSHKANG POCT analyzer. Bland-Altman plots (MS100: 0.8206‒0.9995; MC100: 0.8318‒0.9911) evinced significant consistency between methodologies. Spearman correlation pinpointed a potent linear association between conventional devices and the PUSHKANG POCT analyzer, further underscored by a robust correlation coefficient (MS100: 0.713‒0.949; MC100: 0.593‒0.950). The PUSHKANG POCT was validated as a dependable tool for serum and whole blood biochemical and coagulation diagnostics. This emphasizes its prospective clinical efficacy, offering clinicians a swift diagnostic tool and heralding a new era of enhanced patient care outcomes.  
      Keywords:Thirteen serum biochemical indexes;Five whole blood coagulation indices;Point-of-care testing (POCT);Pulmonary and critical care medicine;Diagnostic protocol   
      18
      |
      27
      |
      0
      <HTML>
      <L-PDF>
      <Citation> <Bulk Citation> 44035767 false
      Updated:2025-02-25
    • Shixu DU, Leqin FANG, Yuanhui LI, Shuai LIU, Xue LUO, Shufei ZENG, Shuqiong ZHENG, Hangyi YANG, Yan XU, Dai LI, Bin ZHANG
      Vol. 26, Issue 2, Pages: 172-184(2025) DOI: 10.1631/jzus.B2300831
      Abstract:Despite that sleep disturbance and poor neurocognitive performance are common complaints among coronavirus disease 2019 (COVID-19) survivors, few studies have focused on the effect of post-COVID-19 sleep disturbance (PCSD) on cognitive function. This study aimed to identify the impact of PCSD on neurocognitive function and explore the associated risk factors for the worsening of this condition. This cross-sectional study was conducted via the web-based assessment in Chinese mainland. Neurocognitive function was evaluated by the modified online Integrated Cognitive Assessment (ICA) and the Number Ordering Test (NOT). Propensity score matching (PSM) was utilized to match the confounding factors between individuals with and without PCSD. Univariate analyses were performed to evaluate the effect of PCSD on neurocognitive function. The risk factors associated with worsened neurocognitive performance in PCSD individuals were explored using binary logistic regression. A total of 8692 individuals with COVID-19 diagnosis were selected for this study. Nearly half (48.80%) of the COVID-19 survivors reported sleep disturbance. After matching by PSM, a total of 3977 pairs (7954 individuals in total) were obtained. Univariate analyses revealed that PCSD was related to worse ICA and NOT performance (P<0.05). Underlying disease, upper respiratory infection, loss of smell or taste, severe pneumonia, and self-reported cognitive complaints were associated with worsened neurocognitive performance among PCSD individuals (P<0.05). Furthermore, aging, ethnicity (minority), and lower education level were found to be independent risk factors for worsened neurocognitive performance in PCSD individuals (P<0.05). PCSD was related to impaired neurocognitive performance. Therefore, appropriate prevention and intervention measures should be taken to minimize or prevent PCSD and eliminate its potential adverse effect on neurocognitive function.  
      Keywords:Coronavirus disease 2019 (COVID-19);Post-COVID-19;Sleep disturbance;Neurocognitive function;Digital assessment   
      6
      |
      0
      |
      0
      <HTML>
      <L-PDF>
      <Citation> <Bulk Citation> 81856020 false
      Updated:2025-02-25
    • Georgi Yu. LAPTEV, Daria G. TIURINA, Elena A. YILDIRIM, Elena P. GORFUNKEL, Larisa A. ILINA, Valentina A. FILIPPOVA, Andrei V. DUBROVIN, Alisa S. DUBROVINA, Evgeni A. BRAZHNIK, Natalia I. NOVIKOVA, Veronika K. MELIKIDI, Kseniya A. SOKOLOVA, Ekaterina S. PONOMAREVA, Vasiliy A. ZAIKIN, Darren K. GRIFFIN, Michael N. ROMANOV
      Vol. 26, Issue 2, Pages: 185-199(2025) DOI: 10.1631/jzus.B2300767
      Abstract:Drugs and pesticide residues in broiler feed can compromise the therapeutic and production benefits of antibiotic (ANT) application and affect gene expression. In this study, we analyzed the expression of 13 key pancreatic genes and blood physiology parameters after administering one maximum residue limit of herbicide glyphosate (GLY), two ANTs, and one anticoccidial drug (AD). A total of 260 Ross 308 broilers aged 1‍–‍40 d were divided into the following four groups of 65 birds each: control group, which was fed the main diet (MD), and three experimental groups, which were fed MD supplemented with GLY, GLY+ANTs (enrofloxacin and colistin methanesulfonate), and GLY+AD (ammonium maduramicin), respectively. The results showed that the addition of GLY, GLY+ANTs, and GLY+AD caused significant changes in the expression of several genes of physiological and economic importance. In particular, genes related to inflammation and apoptosis (interleukin 6 (IL6), prostaglandin-endoperoxide synthase 2 (PTGS2), and caspase 6 (CASP6)) were downregulated by up to 99.1%, and those related to antioxidant protection (catalase (CAT), superoxide dismutase 1 (SOD1) and peroxiredoxin 6 (PRDX6)) by up to 98.6%, compared to controls. There was also a significant decline in the values of immunological characteristics in the blood serum observed in the experimental groups, and certain changes in gene expression were concordant with changes in the functioning of the pancreas and blood. The changes revealed in gene expression and blood indices in response to GLY, ANTs, and AD provide insights into the possible mechanisms of action of these agents at the molecular level. Specifically, these changes may be indicative of physiological mechanisms to overcome the negative effects of GLY, GLY+ANTs, and GLY+AD in broilers.  
      Keywords:Glyphosate;Antibiotic;Anticoccidial drug;Pancreas;Broiler;Gene expression;Blood parameter   
      2
      |
      0
      |
      0
      <HTML>
      <L-PDF>
      <Citation> <Bulk Citation> 84251241 false
      Updated:2025-02-25

      Correspondence

    • Application of custom-made joint prostheses in wrist

      Xiaodi ZOU, Yanzhao DONG, Changxing WANG, Hui LU
      Vol. 26, Issue 2, Pages: 200-202(2025) DOI: 10.1631/jzus.B2400102
      Abstract:手腕关节是高度活动的功能性关节,各种创伤和退行性疾病均可导致严重的疼痛和活动受限。关节置换术是重建关节功能的主要治疗方式,但传统假体存在诸如形状不匹配、植入物-骨界面强度不足导致松动以及骨内生长欠佳等缺陷。三维(3D)打印技术的应用为解决这些问题提供了新的解决方案,能实现更加个性化的设计,并改善假体与骨骼的契合度。本文回顾了手腕关节假体的发展历程,从最早的Swanson假体到当前广泛使用的第四代假体,分析了各代假体的设计特点及临床应用情况。研究发现,相比传统定制假体,3D打印假体在缓解疼痛和恢复关节功能等方面表现更优。但目前关于3D打印假体的长期临床随访数据仍有限,需进一步评估其长期疗效及并发症。此外,金属假体存在的腐蚀问题也是亟待解决的挑战,未来需要通过探索新的生物材料和表面处理技术以提高假体的生物相容性和抗菌性。3D打印技术为手腕关节假体的个性化设计和性能提升带来了新的契机,有望为患者提供更优质的治疗选择。但现有研究仍有待深化,还需在长期临床疗效和新材料开发等方面进一步推进。  
        
      2
      |
      0
      |
      0
      <HTML>
      <L-PDF>
      <Citation> <Bulk Citation> 84251208 false
      Updated:2025-02-25
    0